#hargharmadhuvinca
#hargharvinca
#cancerfreeindia
#diabetesmellitus
#tulsivinca
#gocancer
#Gosugar
#GreenIndiaMission
#mission2030
#madhumeh

PLANT OCEMUM SANCTUM AND PERIWINKLE TODAY AND SHIELD YOURSELF FROM LIFE THREATENING DISEASES

#tulsivinca
(Team)

wishes you a colourfull & eco-friendly holi

Sudden-onset diabetes, whereby blood sugar levels soar overnight in someone with no prior signs such as weight gain, obesity or a family history, may in fact be a cry for help from the pancreas, researchers caution. https://english.mathrubhumi.com/lifestyle/health/sudden-diabetes-pancreas-health-issues-fckkfymp?utm_source=dlvr.it&utm_medium=mastodon #diabetesmellitus #pancreatitis #pancreaticcancer

El #ÁcidoAlfaLipoico es poco eficaz para controlar el #DolorNeuropático, pero ayuda a controlar la hiperglucemia en pacientes con #DiabetesMellitus

NO se recomienda usar #opioides para el #dolor neuropático

#Neuropatía #México #MexicanAcademyOfNeurology #academy #XLIX #AcademiaMexicanaDeNeurología #AMN #Neurology #Neurología

AMP just published!
"A Complex Case of Koolen-De Vries Syndrome Associated with Hypopituitarism and Type 1 Diabetes Mellitus"

A Case Report by Mafalda Félix Cabral, Francisco Branco Caetano, Carla Conceição, Diana Antunes and Lurdes Lopes – A work from Unidade Local de Saúde São José, in Lisbon.

Full paper here:
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/22709

#multipleabnormalities #chromosomes #diabetesmellitus #hypopituitarism #intellectualdisability #genetics #actamedicaportuguesa

What is insulin?
Insulin is a pancreatic hormone that helps the body convert glucose into energy.
#insulin #diabetesmellitus #diabetes #pancreas ... Continue to: https://www.facebook.com/1130092409221646/posts/1134045455493008
Changes in Interleukin-17A Content in the Blood of Patients with Diabetes after COVID-19 - #interleukin17A #COVID19 #diabetesmellitus #cardiovasculardiseases #obesity #blood #diabetes - https://link.springer.com/article/10.3103/S0095452725030065
Changes in Interleukin-17A Content in the Blood of Patients with Diabetes after COVID-19 - Cytology and Genetics

Abstract The level of interleukin-17A (IL-17A) was studied in the blood of 82 patients with diabetes mellitus (DM) who had contracted coronavirus disease 2019 (COVID-19) 2–4 years ago. IL-17A was determined using enzyme immunoassay kits. It was shown that the concentration of the cytokine was significantly higher in diabetic patients and in people who had COVID-19. A difference in cytokine levels in the blood of patients who had mild and severe forms of COVID-19, as well as a positive effect of vaccination, was noted. IL-17A concentration increased with diabetes duration of more than 15 years, with body mass index more than 30 kg/m2 and glycated hemoglobin (Hb1Ac) > 7.5%. COVID-19 additionally increased these indicators. There is a positive effect of metformin on IL-17A concentration in patients with diabetes and high interleukin response to COVID-19 in the absence of biguanide treatment. A positive effect of insulin and type 2 sodium-dependent glucose cotransporter inhibitors (iSGLT-2) was also noted. The amount of IL-17A increases in blood plasma with pathological changes in the left ventricular ejection fraction, glomerular filtration rate, and albuminuria. The study of the concentration of IL-17A in blood plasma depending on the age of patients showed a tendency for decrease in the amount of interleukin with age. A high level of IL-17A is observed in the blood plasma of patients with diabetes who had COVID-19 2–4 years ago comparable to an acute disease. In the absence of treatment of patients with diabetes with glucose-lowering drugs in COVID-19, the level of IL-17A reaches high values. The study of the concentration of IL-17A in blood plasma depending on the age of patients showed a tendency to a decrease in the amount of interleukin in older age groups.

SpringerLink

AMP just published!
"Enhancing Postpartum Care in Gestational Diabetes: A Call for Preventive Action"

A Letter to Editor by Francisca Colaço, Inês Gomes Alves, Serzelina Cunha and Álvaro Mendes – A work from Unidade de Saúde Familiar 3 Rios, in Penafiel.

Full paper here:
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/23306

#diabetesmellitus #diagnosis #gestationaldiabetes #postpartum #actamedicaportuguesa

#Servicetweet #Wissen #Gesundheit #Selbsttests #DiabetesMellitus
➡️ Wie hoch ist das persönliche Risiko Diabetes mellitus Typ 2 zu entwickeln?
➡️ Seriöser Online-Selbsttest
https://www.netdoktor.de/selbsttests/diabetes-selbsttest-typ-2/?utm_source=sendinblue&utm_campaign=&utm_medium=email
Diabetes-Selbsttest: Risiko online testen

Haben Sie ein erhöhtes Risiko für Diabetes Typ 2? Mit dem kostenlosen Diabetes-Selbsttest können Sie Ihre persönlichen Risikofaktoren online überprüfen.

netDoktor

El uso de agonistas del receptor del péptido parecido al glucagon tipo 1 (GLP-1 RAs), —principalmente semaglutida & tirzepatida—, se asoció con reducciones del 37% del riesgo de #demencia, 19% del riesgo de #EVC y de 30% en mortalidad, en adultos con #DiabetesMellitus y #Obesidad
Los efectos de #neuroprotección fueron más pronunciados en adultos mayores, mujeres y gente con IMC 30-40

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2836412